CN105461755B - Platinum complex with aggregation-induced red light emission and preparation method and application thereof - Google Patents

Platinum complex with aggregation-induced red light emission and preparation method and application thereof Download PDF

Info

Publication number
CN105461755B
CN105461755B CN201510856435.0A CN201510856435A CN105461755B CN 105461755 B CN105461755 B CN 105461755B CN 201510856435 A CN201510856435 A CN 201510856435A CN 105461755 B CN105461755 B CN 105461755B
Authority
CN
China
Prior art keywords
aggregation
platinum complex
platinum
complex
light emission
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510856435.0A
Other languages
Chinese (zh)
Other versions
CN105461755A (en
Inventor
许文娟
黄维
胡榕榕
赵强
刘淑娟
孙会彬
杨继光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Post and Telecommunication University
Original Assignee
Nanjing Post and Telecommunication University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Post and Telecommunication University filed Critical Nanjing Post and Telecommunication University
Priority to CN201510856435.0A priority Critical patent/CN105461755B/en
Publication of CN105461755A publication Critical patent/CN105461755A/en
Application granted granted Critical
Publication of CN105461755B publication Critical patent/CN105461755B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/346Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising platinum
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)

Abstract

The invention belongs to the field of organic photoelectric functional materials; in particular to a platinum complex with aggregation-induced red light emission, a preparation method thereof and application of the material in the fields of organic electroluminescence and biological imaging; the material consists of a ring metal ligand, a metal platinum center and an auxiliary ligand, and the structural general formula is as follows; the material has simple synthesis steps and mild conditions, basically does not emit light in a solution state, but has strong red light emission in a solid state; the platinum complex material with aggregation-induced red light emission can be applied to organic electroluminescent devices and biological imaging.
Figure DDA0000862803250000011

Description

Platinum complex with aggregation-induced red light emission and preparation method and application thereof
Technical Field
The invention belongs to the field of organic photoelectric functional materials. In particular to a platinum complex with aggregation-induced red light emission and the application field thereof in the fields of organic photoelectric functional devices and biological imaging.
Background
Phosphorescent transition metal complexes have received much attention from researchers due to their excellent luminescent properties and potential application values in the fields of optoelectronic devices, chemical/biological sensors and bio-imaging. However, as with other organic light-emitting materials, the phosphorescent emission intensity of the transition metal complex also tends to gradually decrease with increasing solution concentration, becoming almost non-light-emitting even in the aggregated state. For example, the more well-known Ir (ppy)3The phosphorescence quantum yield can reach 0.97 under the dilute solution, but the phosphorescence quantum yield drops to 0.03 under the solid thin film state. This is due to aggregation-induced quenching (ACQ), which severely hampers the application of transition metal complexes in many fields, especially those requiring phosphorescent metal complexes to be able to emit light in the aggregated form.
In 2001, Tangbenloyl et al found that silacyclopentadiene derivatives did not substantially emit light in solution, but rather enhanced the emission as the degree of aggregation of the molecules increased, a so-called aggregation-induced emission (AIE) property. The main cause of the formation of such an interesting phenomenon can be expressed as a luminescence enhancement mechanism caused by the inhibition of the rotation within the molecule in an aggregated state, and many organic light emitting molecules having excellent AIE properties have been developed on the basis of such a mechanism and widely used in the fields of organic light emitting diodes, sensing, bio-imaging, and the like. The development of the aggregation-induced emission compound opens up a new way for the wide application of organic light-emitting materials in solid devices. By utilizing the aggregation state induced luminescence property, the problem of reduced luminescence efficiency caused by concentration quenching effect can be solved to a certain extent, and a luminescent material does not need to be doped into a main material when a luminescent device is prepared, so that the preparation process of the device is simplified, and the manufacturing cost of the device is reduced. The work on this aspect is also based on organic fluorescent materials, and in the field of biological imaging, fluorescence as an output signal is often interfered by biological background fluorescence and scattered light [19 ]. An effective solution to this problem is to construct materials with aggregation-induced phosphorescent emission properties (AIPE) to replace the conventional organic fluorescent materials.
Besides the spin-orbit coupling of the phosphorescent iridium complex can be used for improving the quantum efficiency of electroluminescence, the relatively long phosphorescence life of the phosphorescent iridium complex makes the phosphorescent iridium complex become an ideal biological fluorescence imaging labeling dye. Currently, most of the commercial fluorescent dyes used in the field of cell imaging are small organic molecules. However, the organic molecules have poor light stability, large interference of background fluorescence, large cytotoxicity and other defects, which limit the application of the organic molecules in the field of biological imaging. In recent years, the phosphorescent heavy metal iridium complex has attracted great interest as a dye molecule of a fluorescence imaging technology, because the phosphorescent heavy metal iridium complex has the following characteristics different from organic molecules: the fluorescent light has large Stokes displacement and long emission life, the long emission life is beneficial to distinguishing phosphorescent signals from background fluorescent signals by using a time resolution technology, and the fluorescent light has excellent light stability and is convenient for long-time observation.
Disclosure of Invention
The technical problem is as follows: the invention aims to provide a platinum complex with aggregation-induced red light emission, a preparation method thereof and application of the complex in the fields of organic photoelectric devices, biomarkers and cell imaging.
The technical scheme is as follows: the invention relates to a platinum complex with aggregation-induced red light emission, which is characterized by having the following structural formula:
wherein, R can be any one of the following groups:
Figure GDA0002097836660000031
Figure GDA0002097836660000032
any one of the groups of the following structures:
Figure GDA0002097836660000033
the preparation method of the platinum complex with aggregation-induced red light emission comprises the following steps:
Figure GDA0002097836660000034
reacting a fluorine-containing aromatic amine compound with o-hydroxybenzaldehyde, adding a drop of acetic acid into ethanol serving as a solvent to initiate reaction, and stirring for reaction for 2 hours at room temperature to obtain a Schiff base compound; the coordination reaction being in particular N2Under protection, 1 equivalent of potassium chloroplatinite (K)2PtCl4) Dissolving the compound and 2.5 equivalent of cyclometalated ligand in the mixed solution of ethylene glycol ether and water, and carrying out reflux stirring reaction for 12 hours; cooling to room temperature, precipitating, filtering, and drying under infrared lamp to obtain (C ^ N) Pt (mu-Cl)2A Pt (C ^ N) intermediate; then (C ^ N) Pt (mu-Cl)2Pt (C ^ N), 3.0 equivalent of Schiff base compound and 10.0 equivalent of Na2CO3Dissolving in ethylene glycol ethyl ether, and reacting for 12 hours under reflux and stirring; cooling to room temperature after reaction, carrying out suction filtration, carrying out reduced pressure spin-drying on the filtrate, adding dichloromethane for dissolution, and purifying by using a column chromatography method to obtain the platinum complex with aggregation-induced red light emission.
The platinum complex with aggregation-induced red light emission can be applied to the fields of organic electroluminescence, biological imaging and the like.
Has the advantages that:
1. the platinum complex involved in the invention has simple synthesis steps and mild conditions;
2. the platinum complex has strong red light emission in a solid state, and the luminous quantum efficiency in the solid state is more than 5 percent;
3. the platinum complex has large Stokes shift, can easily distinguish excitation from emission, has long luminescence life, can be distinguished from background fluorescence signals by using a time resolution technology so as to improve the signal-to-noise ratio and sensitivity of detection, can be excited by using visible light, and the like.
Drawings
FIG. 1 nuclear magnetic resonance hydrogen spectrum of complex 1 synthesized in the invention
FIG. 2 is a diagram showing the UV-VIS absorption spectrum of the complex 1 synthesized in the present invention in a tetrahydrofuran solution.
FIG. 3 is a graph showing the emission spectra of complex 1 synthesized in the present invention in a tetrahydrofuran solution and in a solid state, respectively.
FIG. 4 is a diagram showing the image of the cell of the complex 1 synthesized in the present invention.
Detailed Description
The invention relates to a structural general formula of a compound as follows:
wherein R may be the following group:
Figure GDA0002097836660000051
is a heterocyclic compound having the structure:
in order to better understand the contents of the present patent, the following further illustrates the technical solution of the present invention by specific examples. The method specifically comprises synthesis, property determination, device preparation experiment, cell imaging and the like. These examples do not limit the invention.
Example 1 preparation of a platinum Complex when R isThe ligand is
Figure GDA0002097836660000055
The method comprises the following steps:
preparation of compound 1 a:
Figure GDA0002097836660000056
dissolving o-hydroxybenzaldehyde (2.3mL,22mmol) in 20mL ethanol, then weighing pentafluoroaniline (4.0g,22mmol) to be dissolved in 20mL ethanol, dropwise adding the pentafluoroaniline to the ethanol solution of o-hydroxybenzaldehyde, adding 1 drop of acetic acid as a catalyst, stirring and reacting for 2 hours at room temperature, concentrating the mixed solution after the reaction is finished, and performing column chromatography separation by using petroleum ether/dichloromethane as an eluent to obtain 5.4g of yellow solid, wherein the yield is as follows: 85 percent.1H NMR(400MHz,CDCl3)δ8.83(s,1H),7.49-7.40(m,2H),7.07-6.97(m,2H).
Figure GDA0002097836660000061
Platinum dichloropyridine bridge ((ppy) Pt (. mu. -Cl)2Preparation of Pt (ppy)): weighing potassium platinochloride (1mmol) and 2-phenylpyridine (2.5mmol), adding into a three-neck flask, vacuumizing on a double-row pipe, filling nitrogen, vacuumizing for three times, and finally protecting the reaction system with nitrogen. Injecting a mixture (3:1v/v) of ethylene glycol ethyl ether and water into a reaction system by using an injector, stirring, heating the reaction system to 110 ℃, and reacting for about 12 hours, wherein a precipitate is generated in the reaction process. The reaction was cooled to room temperature, then the precipitate was filtered and washed with water, ethanol to give a yellow-green solid product, yield: 80 percent.
Preparation of platinum Complex 1:
Figure GDA0002097836660000062
weighing 1 equivalent of platinum dichloro-bridge compound ((ppy) Pt (. mu. -Cl)2Adding Pt (ppy), 3 times of equivalent compound 1a (64mg) and 10 times of equivalent sodium carbonate into a three-mouth bottle, vacuumizing on a double-row pipe, filling nitrogen, vacuumizing for three times, and finally protecting the reaction system by using nitrogen; injecting ethylene glycol ethyl ether by using an injector, heating to 110 ℃, and stirring to react for 12 hours; concentrating the mixture, adding a large amount of water, separating out a platinum complex crude product, filtering, washing with water and diethyl ether, separating the filtered precipitate by column chromatography, removing the solvent in vacuum, and drying to obtain an orange-red solid. Yield: 50 percent.1H NMR(400MHz,DMSO)δ9.38(d,J=5.5Hz,1H),8.73(s,1H),8.15–7.92(m,2H),7.73–7.55(m,2H),7.56–7.39(m,2H),7.05(d,J=8.6Hz,1H),6.94(t,J=7.0Hz,1H),6.81(t,J=6.9Hz,1H),6.63(t,J=7.4Hz,1H),5.55(d,J=7.7Hz,1H).
Example 2: compound characterization
The compound (5-10mg) is dissolved in 0.5ml of deuterated reagent, and the structures of partial compounds are respectively characterized by a 400Hz nuclear magnetic resonance instrument, wherein the nuclear magnetic resonance hydrogen spectrum of the complex 1 in the example 1 is shown in the attached figure 1.
Example 3: ultraviolet-visible absorption spectrum test of complex in tetrahydrofuran solution
A10 mu mol/L tetrahydrofuran solution of the complex is prepared, and an ultraviolet-visible absorption spectrum of the tetrahydrofuran solution is tested on an ultraviolet spectrophotometer, and the absorption spectrum result of the complex 1 is shown in figure 2.
Example 4: emission spectrum of complex in tetrahydrofuran solution and solid state
The emission spectrum of the tetrahydrofuran solution and the emission spectrum of the solid powder of the complex are respectively tested on a fluorescence spectrometer, and the emission spectrum of the complex 1 is shown in figure 3.
Example 6: live cell imaging experiments:
the platinum complex was prepared as a 10mmol/L DMSO solution, and 20. mu.L of the solution was transferred to 2000. mu.L of PBS buffer solution to dilute the solution to a concentration of 10. mu.M. After 2mL of solution is taken to incubate cells for 30 minutes, the cells are washed for 3-5 times by PBS buffer solution, the cells are excited by 405nm wavelength to carry out confocal imaging, and Z scanning and nuclear co-staining data show that the complex has better cell penetration and is distributed in a cytoplasmic region. The image of the living cell of the complex 1 is shown in FIG. 4.

Claims (5)

1. A platinum complex having aggregation-induced red emission, characterized in that the platinum complex has the following structural formula:
Figure FDA0002097836650000011
wherein,
Figure FDA0002097836650000012
a group of any one of the following structures:
Figure FDA0002097836650000013
2. the method for preparing platinum complex with aggregation-induced red light emission according to claim 1, wherein the synthetic route is as follows:
Figure FDA0002097836650000014
Figure FDA0002097836650000015
any one of the groups of the following structures:
Figure FDA0002097836650000016
specifically, firstly, the fluorine-containing arylamine compound reacts with o-hydroxybenzaldehyde, ethanol is used as a solvent, and thenAdding a drop of acetic acid to initiate the reaction, and stirring the mixture for reaction for 2 hours at room temperature to obtain a Schiff base compound; the coordination reaction being in particular N2Under protection, 1 equivalent of potassium chloroplatinite and 2.5 equivalents of a ring metal ligand compound are dissolved in mixed solution of ethylene glycol ether and water, and reflux stirring reaction is carried out for 12 hours; cooling to room temperature, precipitating, filtering, and drying under infrared lamp to obtain (C ^ N) Pt (mu-Cl)2A Pt (C ^ N) intermediate; then (C ^ N) Pt (mu-Cl)2Pt (C ^ N), 3.0 equivalent of Schiff base compound and 5.0 equivalent of Na2CO3Dissolving in ethylene glycol ethyl ether, and reacting for 12 hours under reflux and stirring; cooling to room temperature after reaction, carrying out suction filtration, carrying out reduced pressure spin-drying on the filtrate, adding dichloromethane for dissolution, and purifying by using a column chromatography method to obtain the platinum complex with aggregation-induced red light emission.
3. The application of the platinum complex with aggregation-induced red light emission as claimed in claim 1, wherein the platinum iridium complex is applied to the field of organic electroluminescence, and a device of the platinum iridium complex is of a single-layer or multi-layer structure.
4. Use of a platinum complex with aggregation-induced red emission according to claim 1, characterized in that the platinum complex is applicable for bio-imaging.
5. Use of platinum complexes with aggregation-induced red emission according to claim 1, characterized in that the platinum complexes are used for time-resolved bioimaging.
CN201510856435.0A 2015-11-30 2015-11-30 Platinum complex with aggregation-induced red light emission and preparation method and application thereof Active CN105461755B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510856435.0A CN105461755B (en) 2015-11-30 2015-11-30 Platinum complex with aggregation-induced red light emission and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510856435.0A CN105461755B (en) 2015-11-30 2015-11-30 Platinum complex with aggregation-induced red light emission and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN105461755A CN105461755A (en) 2016-04-06
CN105461755B true CN105461755B (en) 2020-02-07

Family

ID=55599963

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510856435.0A Active CN105461755B (en) 2015-11-30 2015-11-30 Platinum complex with aggregation-induced red light emission and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN105461755B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106632489B (en) * 2016-09-18 2019-04-30 台州学院 A kind of platinum green light material and preparation method thereof containing Schiff base ligand

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101838291A (en) * 2010-05-28 2010-09-22 南京邮电大学 Preparation and application of platinum complex material with aggregated-state induced phosphorescence emission characteristic

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101838291A (en) * 2010-05-28 2010-09-22 南京邮电大学 Preparation and application of platinum complex material with aggregated-state induced phosphorescence emission characteristic

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Photophysical Properties and OLED Applications of Phosphorescent Platinum(II) Schiff Base Complexes";Chi-Ming Che;《Chem. Eur. J.》;20091210;第16卷(第1期);第233-247页 *
"Synthesis, characterization and anticancer properties of Synthesis, characterization and anticancer properties of";Alysssa E.Patterson 等;《Inorganica Chimica Acta》;20140305(第415期);第88-94页 *
"Synthesis, characterization, and anticancer properties of organometallic Schiff base platinum complexes";Stephanie Jean 等;《Canadian Journal of Chemistry》;20150531;第93卷(第10期);第1140-1146页 *
"基于铂配合物的聚集态诱导磷光发射性质的研究";牟鑫 等;《全国第八届有机固体电子过程暨华人有机光电功能材料学术讨论会 论文集》;20101231;第276页 *
"磷光过渡金属配合物的光物理性质调控与应用研究";孙会斌;《中国博士学位论文全文数据库 工程科技I辑》;20141231(第05期);B014-39页 *
磷光功能铂配合物涉及、合成及光电性质研究;牟鑫;《中国硕士学位论文全文数据库 工程科技I辑》;20121231(第04期);B014-362页 *

Also Published As

Publication number Publication date
CN105461755A (en) 2016-04-06

Similar Documents

Publication Publication Date Title
CN107793421B (en) Probe with aggregation-induced emission characteristic and preparation method and application thereof
CN106459095A (en) Metal organic framework (MOF) yellow phosphors and their applications in white light emitting devices
Georgiev et al. Novel PAMAM light-harvesting antennae based on 1, 8-naphthalimide: synthesis, energy transfer, photophysical and pH sensing properties
CN110818743B (en) Preparation method and application of cyclometalated platinum complex with aggregation-induced emission property
CN104151326B (en) Yi Zhong perylene diimides-Rhodamine fluorescent probe and its preparation method and application
Ma et al. A water-soluble tetraphenylethene based probe for luminescent carbon dioxide detection and its biological application
Aranda et al. Vinyl-diazine triphenylamines and their N-methylated derivatives: synthesis, photophysical properties and application for staining DNA
Grabchev et al. Metal ions and protons sensing properties of new fluorescent 4-N-methylpiperazine-1, 8-naphthalimide terminated poly (propyleneamine) dendrimer
Grabchev et al. Photophysical investigations on the sensor potential of novel, poly (propylenamine) dendrimers modified with 1, 8-naphthalimide units
US10144722B2 (en) Carbazole end capped bipyridine compounds and process for preparation thereof
CN101935529A (en) Multifunctional nano-composite having up-conversion luminescence, oxygen sensing and biological connectivity and preparation method thereof
Wu et al. Syntheses, characterization and fluorescent properties of six novel lanthanide complexes with N, N-diphenyl-2-(quinolin-8-yloxy) acetamide
Ruan et al. A simple AIE-active triphenylamine derivative for supersensitive detection of water in organic solvents with noticeable fluorescence color change
CN108516979B (en) Compound based on naphthalimide-rhodamine and application thereof
CN103409134B (en) Bifluorescence-emission organic light-emitting material and preparation method thereof
CN109053741B (en) Preparation method and application of perylene diimide pH fluorescent probe
CN101838291A (en) Preparation and application of platinum complex material with aggregated-state induced phosphorescence emission characteristic
CN105461755B (en) Platinum complex with aggregation-induced red light emission and preparation method and application thereof
CN107759504B (en) Dual-phase organic fluorescent material with strong fluorescence in solid and liquid states and preparation method thereof
Huang et al. N-(2-(N’, N’-Diethylamino) ethyl) perylene-3, 4-dicarboximide and its Quaternized Derivatives as Fluorescence Probes of Acid, Temperature, and Solvent Polarity
CN113387905A (en) Organic room temperature phosphorescent material, preparation method and application
WO2008010532A1 (en) Compound or salt thereof, processes for producing these, aromatic azo compounds, and fluorescent material
CN110117235B (en) Compound with aggregation-induced light emission and mechanochromism characteristics and preparation method and application thereof
CN102731479A (en) Organic ligand, rare earth organic fluorescent probe material thereof and preparation method thereof
CN111253311B (en) Preparation and application of aggregation-induced emission compound based on naphthalimide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant